Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets
Authors
Keywords
Nutrition, Dietary intervention, PCSK9, Insulin resistance, Liver steatosis
Journal
Nutrition & Metabolism
Volume 10, Issue 1, Pages 4
Publisher
Springer Nature
Online
2013-01-10
DOI
10.1186/1743-7075-10-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans
- (2012) Fanny Theytaz et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
- (2012) Helena Bjermo et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamsters
- (2012) Minhao Wu et al. ATHEROSCLEROSIS
- Hepatic Insulin Signaling Is Required for Obesity-Dependent Expression of SREBP-1c mRNA but Not for Feeding-Dependent Expression
- (2012) Joel T. Haas et al. Cell Metabolism
- Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
- (2012) Robert P Giugliano et al. LANCET
- Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
- (2012) Evan A Stein et al. LANCET
- Selection of the appropriate method for the assessment of insulin resistance
- (2011) Anwar Borai et al. BMC Medical Research Methodology
- Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans
- (2010) Lena Persson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Association between plasma PCSK9 and gamma-glutamyl transferase levels in diabetic patients
- (2010) Bertrand Cariou et al. ATHEROSCLEROSIS
- Fasting reduces plasma proprotein convertase, subtilisin/kexin type 9 and cholesterol biosynthesis in humans
- (2010) Jeffrey D. Browning et al. JOURNAL OF LIPID RESEARCH
- Metabolic Effects of Fructose and the Worldwide Increase in Obesity
- (2010) Luc Tappy et al. PHYSIOLOGICAL REVIEWS
- Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes
- (2009) Kim-Anne Lê et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- High protein intake reduces intrahepatocellular lipid deposition in humans
- (2009) Murielle Bortolotti et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial Hypobetalipoproteinemia
- (2009) Bertrand Cariou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected From Postprandial Triglyceridemia
- (2009) Cédric Le May et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PCSK9 is expressed in pancreatic δ-cells and does not alter insulin secretion
- (2009) Cédric Langhi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Plasma PCSK9 Is Associated with Age, Sex, and Multiple Metabolic Markers in a Population-Based Sample of Children and Adolescents
- (2009) A. Baass et al. CLINICAL CHEMISTRY
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A new method for measurement of total plasma PCSK9: clinical applications
- (2009) Geneviève Dubuc et al. JOURNAL OF LIPID RESEARCH
- Dual Mechanisms for the Fibrate-mediated Repression of Proprotein Convertase Subtilisin/Kexin Type 9
- (2008) Sanae Kourimate et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice
- (2008) Yi Luo et al. JOURNAL OF LIPID RESEARCH
- PCSK9 and LDL cholesterol: unravelling the target to design the bullet
- (2008) Philippe Costet et al. TRENDS IN BIOCHEMICAL SCIENCES
- Diabetes alters LDL receptor and PCSK9 expression in rat liver
- (2007) Melissa Niesen et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now